Close Menu

NEW YORK (GenomeWeb News) – Maverix Biomics said this week that it has extended an existing co-marketing agreement with Qiagen by integrating a second set of software products to support customers analyzing data from RNA-sequencing studies.

The partners have combined Qiagen's Ingenuity Pathway Analysis software with the Maverix Analytic platform to simplify the analysis and interpretation of RNA-seq data as well as speed up research, Maverix said. Last November, the companies integrated Qiagen Ingenuity iReport with the Maverix platform.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.